| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |